About Shreegen Pharma Limited
Data last updated:
Shreegen Pharma Limited is a public limited company based in Ameerpet, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 18 October 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24233TG2012PLC083695. Its GSTIN is 29AASCS2680K1ZJ (Karnataka). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Cr and a paid-up capital of ₹25 Cr. It is led by directors including Rama Mangeswar Reddy Bobbiti (Managing Director) and Kanaka Nallamilli Sundara Reddy.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Ameerpet, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹9.2 Cr, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹1.32 Lakh (net margin 0.1%) and EBITDA of ₹75.93 Lakh (EBITDA margin 8.3%). Revenue has declined at a compounded annual rate (CAGR) of 33% over three years and 16% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹11.69 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website shreegen.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressHno. 7 – 1 – 638 To 643 Flat 305 Bhanu Enclave, Beside Esi Hospital Sundernagar Erragadda, Ameerpet, Telangana, India – 500038
- IndustryPharma, API Manufacturers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
CIN History of Shreegen Pharma Limited
Shreegen Pharma has one previous CIN (Corporate Identification Number): U24233AP2012PLC083695. The current CIN is U24233TG2012PLC083695, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24233TG2012PLC083695 | Current |
| U24233AP2012PLC083695 | Previous |
Business Activity of Shreegen Pharma Limited
The main business activity of Shreegen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Shreegen Pharma Limited
Shreegen Pharma Limited is audited by LAKHOTIA & REDDY for the financial year 2021.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| LAKHOTIA & REDDY | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Shreegen Pharma Limited
Shreegen Pharma has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rama Mangeswar Reddy Bobbiti | Managing Director | 18 Oct 2012 | 13 Years 11 Months | Current |
| Kanaka Nallamilli Sundara Reddy Also directs: Symbiosis Feeds India Private Limited | Director | 30 Sep 2016 | 10 Years 0 Months | Current |
| Chandra Balireddy Kotthapalli Also directs: Aqzen Impex Private Limited | Additional Director | 14 May 2025 | 1 Years 4 Months | Current |
| Srinivasa Reddy Daka Also directs: SNR Infratech Private Limited | Director | 18 Oct 2012 | 13 Years 11 Months | Current |
| Rajeev Dinesh Srivastava Also directs: Trounce Life Sciences Private Limited | Additional Director | 14 May 2025 | 1 Years 4 Months | Current |
| Sishtla Ramakrishnan Also directs: Avidia Pharma Labs LLP, Aalto Biotech Private Limited, Srivar Pharma Private Limited and 2 more | Director | 01 Aug 2025 | 1 Years 2 Months | Current |
Financials of Shreegen Pharma Limited FY 2023 filings available
Shreegen Pharma Limited reported revenue of ₹9.2 Cr (down 32% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Shreegen Pharma Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 32% fall in the latest year. EBITDA rose 145% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Shreegen Pharma Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹75.93 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.32 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Shreegen Pharma Limited
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Shreegen Pharma are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Shreegen Pharma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Shreegen Pharma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Apr 2015 | State Bank of India | ₹11.69 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Shreegen Pharma Limited
Shreegen Pharma Limited has a workforce of 26 employees as of Apr 09, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Shreegen Pharma Limited
Shreegen Pharma has 3 GST registrations: 1 active and 2 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AASCS2680K1ZJ | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Shreegen Pharma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Shreegen Pharma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Shreegen Pharma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Shreegen Pharma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Shreegen Pharma Limited
Frequently Asked Questions about Shreegen Pharma Limited
Shreegen Pharma is an active public limited company based in Ameerpet, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 18 October 2012 (14+ years old) and is registered under CIN U24233TG2012PLC083695.
Shreegen Pharma reported revenue of ₹9.2 Cr for FY 2023 (down 32% YoY).
Shreegen Pharma has 6 current directors:
- Rama Mangeswar Reddy Bobbiti - Managing Director
- Kanaka Nallamilli Sundara Reddy - Director
- Chandra Balireddy Kotthapalli - Additional Director
- Srinivasa Reddy Daka - Director
- Rajeev Dinesh Srivastava - Additional Director
- Sishtla Ramakrishnan - Director
Shreegen Pharma reported a net profit of ₹1.32 Lakh (net margin 0.1%) and EBITDA of ₹75.93 Lakh (EBITDA margin 8.3%) for FY 2023, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Shreegen Pharma is -33% over three years and -16% over five years. In the latest year (FY 2023) revenue fell 32%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Shreegen Pharma is 29AASCS2680K1ZJ, registered in Karnataka. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Shreegen Pharma is U24233TG2012PLC083695. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shreegen Pharma was incorporated on 18 October 2012, making it 14+ years old. It is registered with the Registrar of Companies, Hyderabad.
Shreegen Pharma can be reached through the website shreegen.com. Its registered office is in Ameerpet, Telangana, India.